Extending Medicare Reimbursement in Clinical Trials

Extending Medicare Reimbursement in Clinical Trials
Author :
Publisher : National Academies Press
Total Pages : 86
Release :
ISBN-10 : 9780309068888
ISBN-13 : 0309068886
Rating : 4/5 (886 Downloads)

Book Synopsis Extending Medicare Reimbursement in Clinical Trials by : Institute of Medicine

Download or read book Extending Medicare Reimbursement in Clinical Trials written by Institute of Medicine and published by National Academies Press. This book was released on 2000-03-17 with total page 86 pages. Available in PDF, EPUB and Kindle. Book excerpt: Increasingly over the past five years, uncertainty about reimbursement for routine patient care has been suspected as contributing to problems enrolling people in clinical trials. Clinical trial investigators cannot guarantee that Medicare will pay for the care required, and they must disclose this uncertainty to potential participants during the informed consent process. Since Medicare does not routinely "preauthorize" care (as do many commercial insurers) the uncertainty cannot be dispelled in advance. Thus, patients considering whether to enter trials must assume that they may have to pay bills that Medicare rejects simply because they have enrolled in the trial. This report recommends an explicit policy for reimbursement of routine patient care costs in clinical trials. It further recommends that HCFA provide additional support for selected clinical trials, and that the government support the establishment of a national clinical trials registry. These policies (1) should assure that beneficiaries would not be denied coverage merely because they have volunteered to participate in a clinical trial; and (2) would not impose excessive administrative burdens on HCFA, its fiscal intermediaries and carriers, or investigators, providers, or participants in clinical trials. Explicit rules would have the added benefit of increasing the uniformity of reimbursement decisions made by Medicare fiscal intermediaries and carriers in different parts of the country. Greater uniformity would, in turn, decrease the uncertainty about reimbursement when providers and patients embark on a clinical trial.


Extending Medicare Reimbursement in Clinical Trials Related Books

Extending Medicare Reimbursement in Clinical Trials
Language: en
Pages: 86
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2000-03-17 - Publisher: National Academies Press

DOWNLOAD EBOOK

Increasingly over the past five years, uncertainty about reimbursement for routine patient care has been suspected as contributing to problems enrolling people
Extending Medicare Reimbursement in Clinical Trials
Language: en
Pages: 86
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2000-02-17 - Publisher: National Academies Press

DOWNLOAD EBOOK

Increasingly over the past five years, uncertainty about reimbursement for routine patient care has been suspected as contributing to problems enrolling people
Extending Medicare Coverage for Preventive and Other Services
Language: en
Pages: 410
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2000-05-07 - Publisher: National Academies Press

DOWNLOAD EBOOK

This report, which was developed by an expert committee of the Institute of Medicine, reviews the first three services listed above. It is intended to assist po
Principles and Practice of Clinical Trials
Language: en
Pages: 2573
Authors: Steven Piantadosi
Categories: Medical
Type: BOOK - Published: 2022-07-19 - Publisher: Springer Nature

DOWNLOAD EBOOK

This is a comprehensive major reference work for our SpringerReference program covering clinical trials. Although the core of the Work will focus on the design,
A National Cancer Clinical Trials System for the 21st Century
Language: en
Pages: 317
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2010-07-08 - Publisher: National Academies Press

DOWNLOAD EBOOK

The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However,